Skip to main content
Premium Trial:

Request an Annual Quote

Shanna Cotti, Scot Kennedy, Leroy Hood, Ronald Davis, Mostafa Ronaghi, Keith Joho, Nick Tsinoremas, Saeed Tavazoie

Premium
Contract research organization Charles River Laboratories has appointed Shanna Cotti as chief technology officer and has promoted Scot Kennedy to the role of chief of IT solutions engineering. Cotti was most recently a senior consultant for Microsoft, where she managed enterprise-wide technical architecture strategies for Fortune 500 companies. At CRL, Cotti will be responsible for redesigning the company’s global IT initiatives. Kennedy previously was the head of IT for preclinical services at CRL’s Edinburgh site, and for clinical services in all of Europe.
 

 

NextBio has created a scientific advisory board. Founding members include: Leroy Hood, president and co-founder of the Institute for Systems Biology; Ronald Davis, director of the Stanford Genome Technology Center; Mostafa Ronaghi, NextBio co-founder, as well as a co-founder of Pyrosequencing and ParAllele BioScience; Keith Joho, an informatics consultant who has held senior management positions in bioinformatics at Ingenuity Systems, SurroMed, Abgenix, Roche Bioscience, and Sugen; Nick Tsinoremas, senior director of informatics at Scripps Florida; and Saeed Tavazoie, a professor in the department of molecular biology at the Lewis-Sigler Institute for Integrative Genomics at Princeton University.

Filed under

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.